Jay Lichter
Vorsitzender bei JANUX THERAPEUTICS, INC.
Vermögen: 215 859 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Court Turner | M | - |
Avalon Ventures Management LLC
 Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California.
Cellular Approaches, Inc.
 Cellular Approaches, Inc. BiotechnologyHealth Technology Cellular Approaches, Inc. operates in the biotechnology industry. It develops pipeline of innate immunity cell-based therapeutics for the treatment of infectious disease, autoimmunity, neurodegeneration and aging. The company was founded in 2016 and is headquartered in La Jolla, CA.
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | - |
| Sanford J. Madigan | M | - |
Nerio Therapeutics, Inc.
 Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA.
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | - |
| Tighe Reardon | M | 48 |
Cellular Approaches, Inc.
Cellular Approaches, Inc. BiotechnologyHealth Technology Cellular Approaches, Inc. operates in the biotechnology industry. It develops pipeline of innate immunity cell-based therapeutics for the treatment of infectious disease, autoimmunity, neurodegeneration and aging. The company was founded in 2016 and is headquartered in La Jolla, CA.
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California.
Nerio Therapeutics, Inc.
Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA.
COI Pharmaceuticals, Inc.
 COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA. | 10 Jahre |
| Stefan Heller | M | 58 |
Nerio Therapeutics, Inc.
Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA.
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | 5 Jahre |
| Solomon H. Snyder | M | - |
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | 14 Jahre |
| Vickie Capps | F | 62 | 10 Jahre | |
| Kevin Kinsella | M | 78 |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | 41 Jahre |
| Sergio Duron | M | - |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California.
Enlaza Therapeutics, Inc.
 Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron.
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | 3 Jahre |
| Gary Pace | M | 76 |
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | 14 Jahre |
| Nadim Ahmed | M | 56 |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | - |
| Carmine Stengone | M | 48 |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | 12 Jahre |
| David Campbell | M | 65 | 7 Jahre | |
| Sheila Gujrathi | M | 53 | 3 Jahre | |
| Jake Simson | M | 38 | 3 Jahre | |
| Alana McNulty | F | 61 | 3 Jahre | |
| Douglas J. Downs | M | - |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California.
Silarus Therapeutics, Inc.
 Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | - |
| Neil Gibson | M | 67 |
Silarus Therapeutics, Inc.
Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA.
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | - |
| Winston Kung | M | 48 | 2 Jahre | |
| Andy Meyer | M | 40 | 3 Jahre | |
| Brady M. Bohrmann | M | - |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | 17 Jahre |
| Brenda Van Vreeswyk | F | - | 2 Jahre | |
| Jenna Daly | F | - | - | |
| Robin Stevenson | M | - |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | 3 Jahre |
| H. Hogan | M | 61 | 1 Jahre | |
| Madigan Sandy | - | - |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | - |
| Judith Li | F | 40 |
Fortis Therapeutics, Inc.
 Fortis Therapeutics, Inc. BiotechnologyHealth Technology Fortis Therapeutics, Inc. operates as a immuno-oncology biotech company. It focuses on developing new antibody drug conjugate therapies for late-stage multiple myeloma and late-stage prostate cancer. The company is headquartered in La Jolla, CA. | - |
| Thomas DiRaimondo | M | - | 6 Jahre | |
| Jim Branch | M | - | 13 Jahre | |
| Robin Stevens | M | 71 |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | - |
| Peter Sieling | M | - |
John Wayne Cancer Institute
 John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | - |
| Marcos Milla | M | 61 |
Enlaza Therapeutics, Inc.
Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron. | - |
| Rebecca Crane-Okada | F | - |
John Wayne Cancer Institute
John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | - |
| Mark Faries | M | - |
John Wayne Cancer Institute
John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | - |
| Byron Robinson | M | 59 | 2 Jahre | |
| Jesus E. Gonzalez | M | - |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | - |
| Charles Winter | M | - | 3 Jahre | |
| Ronald W. Barrett | M | 68 | 3 Jahre | |
| Anthony Adam Rosenberg | M | 71 |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | - |
| William P. Rutledge | M | 82 |
John Wayne Cancer Institute
John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | - |
| Julia Gouw | F | 64 |
John Wayne Cancer Institute
John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | - |
| Gregory L. Waldorf | M | 56 |
John Wayne Cancer Institute
John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | - |
| Shelley Chu | M | 54 |
Enlaza Therapeutics, Inc.
Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron. | - |
| James Topper | M | 62 |
Enlaza Therapeutics, Inc.
Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron. | - |
| Douglas M. Mancino | M | 74 |
John Wayne Cancer Institute
John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | 11 Jahre |
| Susan P. Stimson | F | 51 |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | 5 Jahre |
| Laura Simon Treml | M | - | 11 Jahre | |
| Eugene Chen | M | - |
Pacific Ridge School
 Pacific Ridge School Other Consumer ServicesConsumer Services Pacific Ridge School operates a school. The non-profit company is based in Carlsbad, CA. | - |
| Stephen L. Tomlin | M | - |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | 23 Jahre |
| Ilesanmi Adesida | M | 74 |
University of Illinois
| 37 Jahre |
| Timothy Scott | M | - |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | - |
| Kirk Malloy | M | 57 |
Pacific Ridge School
Pacific Ridge School Other Consumer ServicesConsumer Services Pacific Ridge School operates a school. The non-profit company is based in Carlsbad, CA. | - |
| Alexey Vinogradov | M | 54 |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | - |
| Marc Nasoff | M | - |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA. | - |
| Ernst Heinen | M | 61 | 12 Jahre | |
| James Pennington | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Craig Tooman | M | 58 | - | |
| Paul Cayer | M | 62 | 15 Jahre | |
| Steven St. Peter | M | 57 | 7 Jahre | |
| Linda Rhodes | M | 74 | 6 Jahre | |
| Ricardo Angel | M | 53 |
University of Illinois
| 6 Jahre |
| Rhonda L. Hellums | F | 52 | 5 Jahre | |
| Christian Weber | M | - |
Carolus Therapeutics, Inc.
 Carolus Therapeutics, Inc. BiotechnologyHealth Technology Carolus Therapeutics, Inc. develops novel products for the treatment of inflammatory diseases. It company focuses on therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines, and prevent or reverse inflammation associated with an array of human diseases, including atherosclerosis, rheumatoid arthritis, multiple sclerosis, sepsis, organ transplantation, and cancer. The company was founded by Jay Lichter, Jürgen Bernhagen, and Christian Weber in 2007 and is headquartered in San Diego, CA. | - |
| Eric Loumeau | M | 61 | 3 Jahre | |
| John C. Ayres | M | 45 | 6 Jahre | |
| David A. Weber | M | 64 | 13 Jahre | |
| Gregory Stein | M | - |
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | - |
| Kristine Peterson | F | 64 |
University of Illinois At Urbana–Champaign
| 6 Jahre |
| Jeffrey Harris | M | - | - | |
| Robert Gerber | M | 61 | 6 Jahre | |
| Kenneth L. Serota | M | - |
University of Illinois
| 7 Jahre |
| Jon Erickson | M | 58 |
University of Illinois
| 6 Jahre |
| Doo-Hwan Kim | M | - |
University of Illinois
| 7 Jahre |
| Allen E. Hoover | M | - |
University of Illinois
| 7 Jahre |
| Laurence Kent Hayward | M | - |
University of Illinois
| 5 Jahre |
| Chien Wen Chen | M | 69 |
University of Illinois At Urbana–Champaign
| 3 Jahre |
| Rasim Kaan Aytogu | M | 63 |
University of Illinois
| 7 Jahre |
| Po Chin Lu | M | 65 |
University of Illinois At Urbana–Champaign
| 5 Jahre |
| Harischandra Abeygunawardena | M | 76 |
University of Illinois At Urbana–Champaign
| 3 Jahre |
| Eliot Charles | M | 62 |
University of Illinois At Urbana–Champaign
| 5 Jahre |
| David Overhauser | M | - |
University of Illinois
| 5 Jahre |
| Ioannis Kanellakopoulos | M | - |
University of Illinois
| 4 Jahre |
| Haris Basit | M | 63 |
University of Illinois
| 6 Jahre |
| Rob Roy | M | - |
University of Illinois
| 4 Jahre |
| Irvine O. Hockaday | M | 88 | 5 Jahre | |
| Robert P. Roche | M | 68 | 5 Jahre | |
| Dan Marriott | M | 61 |
University of Illinois
| 5 Jahre |
| Nardin L. Baker | M | - |
University of Illinois
| 6 Jahre |
| Ronald James Domanico | M | 65 |
University of Illinois At Urbana–Champaign
| 6 Jahre |
| Merilee Raines | F | 68 | 5 Jahre | |
| Wendy Yarno | F | 69 | 6 Jahre | |
| John W. Vander Vort | M | 59 | 7 Jahre | |
| Jason Jingsheng Cong | M | 61 |
University of Illinois
| 4 Jahre |
| Peter Bisgaard | M | 50 | 5 Jahre | |
| Jim Li | M | - |
University of Illinois
| 4 Jahre |
| Joy Laskar | M | - |
University of Illinois
| 3 Jahre |
| Tomas Kirvaitis | M | - |
University of Illinois
| 8 Jahre |
| Paula Maggio | F | 55 |
University of Illinois
| 7 Jahre |
| Ann Marie Reo | F | - |
University of Illinois
| 5 Jahre |
| Denis Labij | M | - |
University of Illinois
| 5 Jahre |
| Cynthia Clarke | F | - |
University of Illinois At Urbana–Champaign
University of Illinois
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jay Lichter
- Persönliches Netzwerk
